Globus Medical
GMED
269 hedge funds and large institutions have $3.3B invested in Globus Medical in 2019 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 86 increasing their positions, 105 reducing their positions, and 66 closing their positions.
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
12% more capital invested
Capital invested by funds: $2.95B → $3.3B (+$346M)
3% less call options, than puts
Call options by funds: $4.92M | Put options by funds: $5.09M
2.21% less ownership
Funds ownership: 89.89% → 87.67% (-2.2%)
11% less funds holding
Funds holding: 303 → 269 (-34)
18% less repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 105
48% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 66
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$23.8M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$22M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$12.7M |
| 4 |
SCM
Sio Capital Management
New York
|
+$9.18M |
| 5 |
NI
Nuance Investments
Kansas City,
Missouri
|
+$8.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$29.2M |
| 2 |
Morgan Stanley
New York
|
-$27.9M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$20.2M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$13.6M |
| 5 |
Bank of New York Mellon
New York
|
-$13.4M |
GMED Hedge Fund Activity: Q1 2019 in Review
269 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q1 2019, worth a combined $3.3B — up 12% from $2.95B a quarter earlier.
Sellers outnumbered buyers: 66 funds closed out of GMED and 34 opened new positions — a net loss of 32 holders — while 105 trimmed existing stakes and 86 added.
The largest buyer was Janus Henderson Group, adding an estimated $23.8M. The largest seller was Fidelity Investments, cutting an estimated $29.2M.
- 269 institutional investors held Globus Medical (GMED) as of Q1 2019, down from 303 in Q4 2018.
- Funds reported $3.3B of Globus Medical stock for Q1 2019, up 12% quarter-over-quarter.
- 34 funds opened new Globus Medical positions in Q1 2019 and 66 closed out, a net change of -32 holders.
- The largest Globus Medical buyer in Q1 2019 was Janus Henderson Group, an estimated $23.8M added.
- The largest Globus Medical seller in Q1 2019 was Fidelity Investments, an estimated $29.2M sold.
Based on aggregated 13F filings for Q1 2019.